Literature DB >> 19570651

Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats.

Justin R Gregg1, Nicole R Herring, Alipi V Naydenov, Ryan P Hanlin, Christine Konradi.   

Abstract

Abnormalities of brain white matter and oligodendroglia are among the most consistent findings in schizophrenia (Sz) research. Various gene expression microarray studies of post-mortem Sz brains showed a downregulation of myelin transcripts, while imaging and microscopy studies demonstrated decreases in prefrontal cortical (PFC) white matter volume and oligodendroglia density. Currently, the extent to which reduced oligodendrocyte markers contribute to pathophysiological domains of Sz is unknown. We exposed adolescent rats to cuprizone (CPZ), a copper chelator known to cause demyelination in mice, and examined expression of oligodendrocyte mRNA transcripts and PFC-mediated behavior. Rats on the CPZ diet showed decreased expression of mRNA transcripts encoding oligodendroglial proteins within the medial PFC, but not in the hippocampus or the striatum. These rats also displayed a specific deficit in the ability to shift between perceptual dimensions in the attentional set-shifting task, a PFC-mediated behavioral paradigm modeled after the Wisconsin Card Sorting Test (WCST). The inability to shift strategies corresponds to the deficits exhibited by Sz patients in the WCST. The results demonstrate that a reduction in oligodendrocyte markers is associated with impaired PFC-mediated behaviors. Thus, CPZ exposure of rats can serve as a model to examine the contribution of oligodendrocyte perturbation to cognitive deficits observed in Sz.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570651      PMCID: PMC2768476          DOI: 10.1016/j.schres.2009.05.023

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  72 in total

Review 1.  White matter in learning, cognition and psychiatric disorders.

Authors:  R Douglas Fields
Journal:  Trends Neurosci       Date:  2008-06-05       Impact factor: 13.837

Review 2.  The cognitive neuroscience of schizophrenia.

Authors:  Deanna M Barch
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

Review 3.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

4.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort.

Authors:  K F Berman; R F Zec; D R Weinberger
Journal:  Arch Gen Psychiatry       Date:  1986-02

5.  Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.

Authors:  Thomas Skripuletz; Maren Lindner; Alexandra Kotsiari; Niklas Garde; Jantje Fokuhl; Franziska Linsmeier; Corinna Trebst; Martin Stangel
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

Review 6.  Mechanisms for copper acquisition, distribution and regulation.

Authors:  Byung-Eun Kim; Tracy Nevitt; Dennis J Thiele
Journal:  Nat Chem Biol       Date:  2008-03       Impact factor: 15.040

Review 7.  The myelin-pathogenesis puzzle in schizophrenia: a literature review.

Authors:  G Karoutzou; H M Emrich; D E Dietrich
Journal:  Mol Psychiatry       Date:  2007-10-09       Impact factor: 15.992

8.  Cuprizone neurotoxicity in the rat: morphologic observations.

Authors:  S Love
Journal:  J Neurol Sci       Date:  1988-04       Impact factor: 3.181

9.  Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes.

Authors:  L Xiao; H Xu; Y Zhang; Z Wei; J He; W Jiang; X Li; L E Dyck; R M Devon; Y Deng; X M Li
Journal:  Mol Psychiatry       Date:  2007-08-07       Impact factor: 15.992

Review 10.  The evolution of drug development in schizophrenia: past issues and future opportunities.

Authors:  William T Carpenter; James I Koenig
Journal:  Neuropsychopharmacology       Date:  2007-11-28       Impact factor: 7.853

View more
  26 in total

1.  Impaired copper transport in schizophrenia results in a copper-deficient brain state: A new side to the dysbindin story.

Authors:  Kirsten E Schoonover; Stacy L Queern; Suzanne E Lapi; Rosalinda C Roberts
Journal:  World J Biol Psychiatry       Date:  2018-12-20       Impact factor: 4.132

2.  Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia.

Authors:  Gen Yan; Yinghua Xuan; Zhuozhi Dai; Zhiwei Shen; Guishan Zhang; Haiyun Xu; Renhua Wu
Journal:  Neurochem Res       Date:  2014-10-28       Impact factor: 3.996

Review 3.  Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis.

Authors:  Christine Konradi; Stephanie E Sillivan; Hayley B Clay
Journal:  Neurobiol Dis       Date:  2011-02-17       Impact factor: 5.996

4.  Cortical copper transporter expression in schizophrenia: interactions of risk gene dysbindin-1.

Authors:  Kirsten E Schoonover; William M Kennedy; Rosalinda C Roberts
Journal:  J Neural Transm (Vienna)       Date:  2021-04-22       Impact factor: 3.575

Review 5.  Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia.

Authors:  Nagahide Takahashi; Takeshi Sakurai; Kenneth L Davis; Joseph D Buxbaum
Journal:  Prog Neurobiol       Date:  2010-10-13       Impact factor: 11.685

6.  Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.

Authors:  Haiyun Xu; Hong-Ju Yang; Bryan McConomy; Ronald Browning; Xin-Min Li
Journal:  Front Behav Neurosci       Date:  2010-03-18       Impact factor: 3.558

7.  Cuprizone short-term exposure: astrocytic IL-6 activation and behavioral changes relevant to psychosis.

Authors:  Tomoaki Tezuka; Makoto Tamura; Mari A Kondo; Masaki Sakaue; Kinya Okada; Kana Takemoto; Atsushi Fukunari; Keiko Miwa; Hiromitsu Ohzeki; Shin-ichi Kano; Hiroshi Yasumatsu; Akira Sawa; Yasushi Kajii
Journal:  Neurobiol Dis       Date:  2013-07-16       Impact factor: 5.996

8.  Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone.

Authors:  Haiyun Xu; Hong-Ju Yang; Xin-Min Li
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-06-01       Impact factor: 5.270

9.  Interactions between knockout of schizophrenia risk factor Dysbindin-1 and copper metabolism in mice.

Authors:  Kirsten E Schoonover; Laura J McMeekin; Charlene B Farmer; Neelu E Varghese; Stacy L Queern; Suzanne E Lapi; Rita M Cowell; Rosalinda C Roberts
Journal:  Brain Res Bull       Date:  2020-08-12       Impact factor: 4.077

Review 10.  Myelin, copper, and the cuprizone model of schizophrenia.

Authors:  Nicole R Herring; Christine Konradi
Journal:  Front Biosci (Schol Ed)       Date:  2011-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.